SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Let's Talk About Our Feelings!!!
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Constant Reader who wrote (72694)1/20/2000 5:33:00 PM
From: Lizzie Tudor   of 108807
 
I'm not really up to date on the Clinton prescription drug entitlement - there really are two problems I think, one is the larger issue of drugs in general costing more money in this country, because there is NO regulation... the companies use the US revenue to finance all R&D but the same drugs are available in Mexico or Canada for a fraction of the cost.

There was a guy in line at the drugstore once who paid $300. for a bottle of pills I remember. I wonder what that same prescription would cost in Mexico... not $300. I'll bet - (there are some drugs that legitimately cost a lot of produce... drugs for hemopheliacs are like that I know... but in general drugs cost too much here).

I am opposed to any new entitlements, but I am really opposed to a drug entitlement which is essentially an offset charge to fund R&D for drug companies in the US. This could cost a huge amt of money and again is an example of politicians avoiding the difficult questions and taking the easy fix route.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News